The development of Herceptin, the first monoclonal cancer treatment
Herceptin is a breast cancer drug that reduces the chance of the cancer coming back by a third. It was developed using rats, mice, hamsters and macaques, and was the first monoclonal antibody used to treat cancer.
This presentation outlines the research and development that led to Herceptin.